Richmond Pharmacology is delighted to confirm an upcoming event alongside the Department of International Trade in the US.
Early Phase Drug Development in the UK is to take place Friday 28th of September in Boston, MA.
The event which is to host speakers from both Richmond Pharmacology and UK regulators continues a long line of events staged between Richmond Pharmacology and the DIT around the world. Full details found below including how to express interest in attending the event.
Friday, 28 September 2018
650 East Kendall St,
Cambridge, MA 02142
I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.
Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.
Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we areRead more ›
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophreniaRead more ›
Richmond Pharmacology have developed a resourceful way to use study equipment to help reduce waste produced on siteRead more ›